Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

DCIR found as potential therapeutic target for atopic dermatitis

March 5, 2018

Merck KGaA divulges novel BTK inhibitors

March 5, 2018

Valeant enters licensing agreement with Kaken for KP-470-based products for psoriasis

March 1, 2018

Mirikizumab improves quality of life of patients with moderate to severe psoriasis

Feb. 21, 2018

Umeclidinium has clinical effects in phase II study in palmar hyperhidrosis

Feb. 21, 2018

BirchBioMed's topical kynurenic acid formulation is safe in healthy volunteers

Feb. 20, 2018

Eli Lilly initiates phase I study of LY-3316531

Feb. 20, 2018

Galderma signs joint research agreement on atopic dermatitis with Icahn and Northwestern University

Feb. 19, 2018

Avillion opens IND for phase II study of Merck KGaA's M-1095

Feb. 19, 2018

Pfizer's PF-04965842 granted FDA breakthrough therapy designation for atopic dermatitis

Feb. 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...